Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.

Autor: van den Brand M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Michiel.vandenBrand@radboudumc.nl., Garcia-Garcia M; Department of Pathology, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., Mathijssen JJ; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Colomo L; Department of Pathology, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., Groenen PJ; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Serrano S; Department of Pathology, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain., van Krieken JH; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jazyk: angličtina
Zdroj: Pathology, research and practice [Pathol Res Pract] 2016 Feb; Vol. 212 (2), pp. 148-50. Date of Electronic Publication: 2015 Dec 09.
DOI: 10.1016/j.prp.2015.12.001
Abstrakt: Follicular lymphomas are characterized by overexpression of BCL2 which, in the large majority of cases, is due to a t(14;18) translocation which juxtaposes the BCL2 locus to the immunoglobulin heavy chain locus (IGH). Here, we report partial absence of BCL2 immunohistochemical staining in a case of FL, due to a mutation in the part of BCL2 that encodes the epitope for the most frequently used antibody against BCL2. This finding shows that mutations in BCL2 occur in an ongoing process in follicular which can give rise to unusual immunohistochemical staining patterns.
(Copyright © 2015 Elsevier GmbH. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: